Showing results (1521-1530 of 6,509) with videos related to

Sort By:
Pageof 651
Cancer Immunology, Immunotherapy : CII|February 13, 2024
Synergistic combination therapy using cowpea mosaic virus intratumoral immunotherapy and Lag-3 checkpoint blockadeSweta Karan, Eunkyeong Jung, Christine Boone, et al.
Cancer Immunology, Immunotherapy : CII|February 13, 2024
Investigating the immunological function of alpha-2-glycoprotein 1, zinc-binding in regulating tumor response in the breast cancer microenvironmentToru Hanamura, Kozue Yokoyama, Shigehisa Kitano, et al.
Cancer Immunology, Immunotherapy : CII|February 13, 2024
Targeting monoamine oxidase A: a strategy for inhibiting tumor growth with both immune checkpoint inhibitors and immune modulatorsYifan Ma, Hanmu Chen, Hui Li, et al.
Cancer Immunology, Immunotherapy : CII|February 13, 2024
Distinct profiles of proliferating CD8+/TCF1+ T cells and CD163+/PD-L1+ macrophages predict risk of relapse differently among treatment-naïve breast cancer subtypesKonstantinos Ntostoglou, Sofia D P Theodorou, Tanja Proctor, et al.
Cancer Immunology, Immunotherapy : CII|February 13, 2024
Targeting metabolic sensing switch GPR84 on macrophages for cancer immunotherapyJianying Li, Anjun Ma, Ruohan Zhang, et al.
Cancer Immunology, Immunotherapy : CII|April 2, 2024
Bifidobacterium modulation of tumor immunotherapy and its mechanismBo Pei, Shixuan Peng, Chuying Huang, et al.
Cancer Immunology, Immunotherapy : CII|February 17, 2024
Chemokine CCL21 determines immunotherapy response in hepatocellular carcinoma by affecting neutrophil polarizationWenxin Xu, Jialei Weng, Minghao Xu, et al.
Cancer Immunology, Immunotherapy : CII|February 24, 2024
Toripalimab, a therapeutic monoclonal anti-PD-1 antibody with high binding affinity to PD-1 and enhanced potency to activate human T cellsNarendiran Rajasekaran, Xiaoguang Wang, Sruthi Ravindranathan, et al.
Cancer Immunology, Immunotherapy : CII|January 28, 2024
A comprehensive pan-cancer analysis of prognostic value and potential clinical implications of FTH1 in cancer immunotherapyYuejun Luo, Chengming Liu, Yuxin Yao, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2024
Characterization of T cell receptor repertoire in penile cancerJunying Zhang, Yapeng Wang, Yiqiang Huang, et al.
Pageof 651